BOTHELL, Wash., Feb. 7 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. , a leader in developing therapeutics using advanced molecular biology-based drug delivery technologies, will be presenting at the BIO CEO & Investor Conference on Wednesday, February 15, 2006, at 11:30 a.m. Eastern Time, at The Waldorf Astoria in New York City. Steven C. Quay, M.D., Ph.D., Chairman, President and CEO of Nastech, will provide a corporate overview, including a review of the Company’s product development programs.
To access the live audio webcast for this conference, please log on to Nastech’s website at http://www.nastech.com approximately 15 minutes prior to the presentation in order to register and download any necessary software. A replay of the audio presentation will be available following the event.
About Nastech
We are a pharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. We and our collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com.
CONTACTS: Nastech Pharmaceutical Company Inc. Ed Bell Senior Investor Relations Manager (425) 908-3639 ir@nastech.com Noonan Russo Matthew Haines (Investors/Media) (212) 845-4235
Nastech Pharmaceutical Company Inc.
CONTACT: Ed Bell, Senior Investor Relations Manager of NastechPharmaceutical Company Inc., +1-425-908-3639, ir@nastech.com; orInvestors/Media: Matthew Haines of Noonan Russo, +1-212-845-4235
Web site: http://www.nastech.com/
